Issued Patents All Time
Showing 1–25 of 77 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421236 | Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor | Shuhui CHEN | 2025-09-23 |
| 12391707 | Preparation method for oxazepine compound | Yanbin HU, Fei Sun | 2025-08-19 |
| 12338263 | Antibacterial aminoglycoside derivatives | Dongdong TANG, Zhigang Huang, Cheng LI, Shuhui CHEN | 2025-06-24 |
| 12325695 | 5-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitor | Xiangyu FU, Lihong Hu, Shuhui CHEN | 2025-06-10 |
| 12310948 | Application of monocyclic β-lactam compound in pharmacy | Xiawei WEI, Jian Li, Shuhui CHEN, Yuquan Wei | 2025-05-27 |
| 12221432 | Estrogen receptor antagonist | Shuwen DUAN, Jianyu LU, Lihong Hu, Guoping HU, Jian Li +1 more | 2025-02-11 |
| 12122780 | Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor | Xile LIU, Shuhui CHEN, Lihong Hu, Haiwen Wan | 2024-10-22 |
| 12103936 | Crystal form of hepatitis B surface antigen inhibitor | Yanbin HU, Fei Sun, Shenyi Shi, Yanxiao Su | 2024-10-01 |
| 12098127 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Huijun HE, Shenyi Shi, Jianyu LU, Lihong Hu, Bin Shi +3 more | 2024-09-24 |
| 12071435 | TLR8 agonist | Fei Sun, Zhe CAI, Shuhui CHEN | 2024-08-27 |
| 12054482 | TLR8 agonist | Zhe CAI, Fei Sun, Shuhui CHEN | 2024-08-06 |
| 12018027 | Macrocyclic derivatives acting as XIa factor inhibitor | Yaxian Cai, Xiaobing Yan, Ting Wang, Chengde Wu, Shuhui CHEN | 2024-06-25 |
| 11807647 | Crystal form of hepatitis B surface antigen inhibitor and application thereof | Zhe CAI, Fei Sun | 2023-11-07 |
| 11718610 | Compounds containing benzosultam | Xile LIU, Shuhui CHEN, Lihong Hu, Haiwen Wan, Xiu Jiang | 2023-08-08 |
| 11691974 | 3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors | Xiangyu FU, Lihong Hu, Jianyu LU, Wen Jiang, Jian Li +1 more | 2023-07-04 |
| 11655248 | Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor | Yaxian Cai, Zhaobing Xu, Hailong Yang, Shiqi Han, Guoping HU +3 more | 2023-05-23 |
| 11623923 | Uracil compound as c-MET/AXL inhibitor | Jinping LI, Xiongbin XU, Gang Li, Lihong Hu, Yaling Zhou +3 more | 2023-04-11 |
| 11572372 | Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds | Lifang Wu, Fei Sun, Jinhua DU, Shuhui CHEN, Xiquan Zhang +2 more | 2023-02-07 |
| 11530196 | Pyrimidine compound acting on EGFR and ERBB2 | Lu Zhang, Xile LIU, Lihong Hu, Wen Jiang, Jian Li +1 more | 2022-12-20 |
| 11465986 | Crystal form of c-MET inhibitor and salt form thereof and preparation method therefor | Xiongbin XU, Gang Li, Ting YAO, Kun Wang, Lihong Hu | 2022-10-11 |
| 11459323 | Monocyclic β-lactam compound for treating bacterial infection | Lianghu Gu, Wei LUO, Zhigang Huang, Cheng LI, Shuhui CHEN | 2022-10-04 |
| 11453667 | Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor | Yaxian Cai, Zhaobing Xu, Hailong Yang, Shiqi Han, Guoping HU +3 more | 2022-09-27 |
| 11390625 | Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor | Lingyun WU, Xile LIU, Shuhui CHEN, Lihong Hu, Lele ZHAO +5 more | 2022-07-19 |
| 11358950 | SMAC mimetics used as IAP inhibitors and use thereof | Yingchun Liu, Zhaobing Xu, Lihong Hu, Xingxun Zhu, Guoping HU +2 more | 2022-06-14 |
| 11261196 | Salt serving as AKT inhibitor and crystal thereof | Gang Li, Lun Lu, Qingqing Lu, Lihong Hu | 2022-03-01 |